oa Stenotrophomonas Maltophilla Isolated from the Sputum of the Patient with Cystic Fibrosis Mutation I1234V: First Qatari Report

References

1. Guwitz D, Corey M, Francis PWJ, Crozier D, Levson H. Perspectives in cystic fibrosis. Pediatr Clin North Am. 1979; 26::603–615.
   [Google Scholar]
2. Davis PB, Drumm M, Konstan M. Cystic fibrosis. Am J Respir Crit Care Med. 1996; 154::1229–1256.
   [Google Scholar]
3. Kulczycki LL, Murphy TM, Bellanti JA. Pseudomonas colonization in cystic fibrosis. JAMA. 1978; 240::30–34.
   [Google Scholar]
4. Less CM, Smyth RL. The current management of cystic fibrosis. Int J Clin Pract. 2000; 54::171–179.
   [Google Scholar]
5. Denton M. Stenotrophomonas maltophilia: An emerging problem in cystic fibrosis patients. Rev Med Microbiol. 1997; 8::15–19.
   [Google Scholar]
6. Blessing J, Walker J, Maybury B, Yeager AS, Lewiston N. Pseudomonas cepacia and Pseudomonas maltophilia in the cystic fibrosis patients. Am Rev Respir Dis. 1979; 119::262.
   [Google Scholar]
7. Morrison AJ, Hoffmann KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol. 1986; 24::52–55.
   [Google Scholar]
8. Marshal WF, Keating MR, Anhalt JP, Stechelberg JM. Xanthomonas maltophilia an emerging nosocomial pathogen. Mayo Clin Proc. 1989; 64::1097–1104.
   [Google Scholar]
9. Karpati F, Malmborg AS, Alfredsson H, Hjelte L, Strandvik B. Bacterial colonization with Xanthomonas maltophilia - A retrospective study in cystic fibrosis patient population. Infection. 1994; 22::258–263.
   [Google Scholar]
10. Demko CA, Stern RC, Doershuk CF. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr. Pulmonol. 1998; 25::304–308.
    [Google Scholar]
11. Ballestero S, Virseda I, Escobar H, Suarez L, Baquero F. Stenotrophomonas maltophilia in cystic fibrosis. Eur J Clin Microbiol Infect Dis. 1995; 14::728–729.
    [Google Scholar]
12. Talmaciu I, Varlotta L, Mortensen J, Schidlow DV. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr. Pulmonol. 2000; 30::10–15.
    [Google Scholar]
13. Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobilial agents: impliction for therapy. Antimicrob Agents Chemother. 1994; 38::624–627.
    [Google Scholar]
14. Quinn JP. Clinical Problems Posed by Mutiresistant Nonfermenting Gram-Negative Pathogens. CID. 1998; 27:Suppl 1.
    [Google Scholar]
15. Abdul Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M. Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation 11234V. J Trop Pediat. 2001; 47::110–112.
    [Google Scholar]